CIPLA LTD FDA Approval ANDA 090958

ANDA 090958

CIPLA LTD

FDA Drug Application

Application #090958

Documents

Letter2014-02-27

Application Sponsors

ANDA 090958CIPLA LTD

Marketing Status

None (Tentative Approval)001

Application Products

001TABLET; ORAL200MG; 300MG0EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEEMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

FDA Submissions

ORIG1TA2014-02-26

Submissions Property Types

ORIG1Null19

TE Codes

001PrescriptionAB

CDER Filings

CIPLA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90958
            [companyName] => CIPLA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","activeIngredients":"EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","strength":"200MG; 300MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","submission":"EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","actionType":"200MG; 300MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.